Evidence map›Paper›PMID 28721222›Full record

ArticleNew microbes and new infections2017

Serological evidence of

J Njeru, H Tomaso, K Mertens, K Henning, G Wareth, R Heller, S Kariuki, E M Fèvre, H Neubauer, M W Pletz

Abstract read
In one paragraph

Article in New microbes and new infections, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. The Threat of Vector-Borne Diseases in Sierra Leone.The American journal of tropical medicine and hygiene · 2023
    Review
  4. Article
  5. Review
  6. Seroepidemiology, Spatial Distribution, and Risk Factors ofThe American journal of tropical medicine and hygiene · 2020
    Article
  7. Frontiers in cellular and infection microbiology · 2020
    Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

J NjeruInstitute of Bacterial Infections and Zoonoses, Friedrich-Loeffler-Institute, Jena, Germany.
H TomasoInstitute of Bacterial Infections and Zoonoses, Friedrich-Loeffler-Institute, Jena, Germany.
K MertensInstitute of Bacterial Infections and Zoonoses, Friedrich-Loeffler-Institute, Jena, Germany.
K HenningInstitute of Bacterial Infections and Zoonoses, Friedrich-Loeffler-Institute, Jena, Germany.
G WarethInstitute of Bacterial Infections and Zoonoses, Friedrich-Loeffler-Institute, Jena, Germany.
R HellerInstitute for Molecular Cell Biology, Center for Molecular Biomedicine, Friedrich Schiller University of Jena, Jena, Germany.
S KariukiCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
E M FèvreInstitute of Infection and Global Health, University of Liverpool, Liverpool, UK.
H NeubauerInstitute of Bacterial Infections and Zoonoses, Friedrich-Loeffler-Institute, Jena, Germany.
M W PletzCentre for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.

Funding

Biotechnology and Biological Sciences Research Council BB/L019019/1
6 · The paper itself

Abstract

Tularaemia is a highly contagious infectious zoonosis caused by the bacterial agent

Indexed as

FeverFrancisella tularensisKenyaseroprevalencezoonoses

Identifiers

PMID28721222
PMCPMC5498284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.